{
    "clinical_study": {
        "@rank": "149799", 
        "arm_group": [
            {
                "arm_group_label": "Galactooligosaccharides", 
                "arm_group_type": "Experimental", 
                "description": "addition of 0,5g galactooligosaccharides to HA (hypoallergenic) starter formula"
            }, 
            {
                "arm_group_label": "Only HA formula", 
                "arm_group_type": "No Intervention", 
                "description": "only standard HA starter formula"
            }
        ], 
        "brief_summary": {
            "textblock": "Addition of prebiotic galactooligosaccharides to hypoallergenic starter formula would lead\n      to decreased allergic (atopic) symptoms in nonbreastfed infants with a positive history of\n      allergy in family"
        }, 
        "brief_title": "Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Atopic Dermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Atopic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  nonbreastfed eutrophic infants of corresponding gestational age\n\n          -  presence of a positive family allergic anamnesis in parents or siblings (atopic\n             eczema,   allergic rhinitis or bronchial asthma)\n\n        Exclusion Criteria:\n\n          -  children with serious disease,\n\n          -  breastfed children\n\n          -  children fed another formula then the ones used"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "8 Weeks", 
            "minimum_age": "6 Weeks"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 2, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077088", 
            "org_study_id": "1.090"
        }, 
        "intervention": {
            "arm_group_label": "Galactooligosaccharides", 
            "description": "addition of food grade GRAS (Generally Regarded As Safe) galactooligosaccharides", 
            "intervention_name": "galactooligosaccharide", 
            "intervention_type": "Other", 
            "other_name": [
                "GOS", 
                "prebiotics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "interventional", 
            "doubleblind", 
            "randomised", 
            "pediatric", 
            "prebiotic", 
            "atopic", 
            "dermatitis", 
            "infant"
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ostrava-Vitkovice", 
                    "country": "Czech Republic", 
                    "zip": "70384"
                }, 
                "name": "Vitkovice Hospital"
            }
        }, 
        "location_countries": {
            "country": "Czech Republic"
        }, 
        "number_of_arms": "2", 
        "official_title": "Double Blind, Randomised Study on the Effect of Prebiotics on Incidence of Atopic Manifestations in Infants", 
        "other_outcome": {
            "measure": "incidence of febrile episodes", 
            "safety_issue": "Yes", 
            "time_frame": "at 6 months"
        }, 
        "overall_official": {
            "affiliation": "Vitkovice Hospital, Ostrava, Czech Republic", 
            "last_name": "Jan Bozensky, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Czech Republic: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "objective evaluation of atopic symptoms", 
            "measure": "SCORAD (SCORing Atopic  Dermatitis score) assessment of atopy", 
            "safety_issue": "No", 
            "time_frame": "at  6 months of age"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077088"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "anthropometric parameters (height, weight)", 
            "safety_issue": "Yes", 
            "time_frame": "at  6 months of age"
        }, 
        "source": "Humana Co.Ltd.", 
        "sponsors": {
            "collaborator": {
                "agency": "Vitkovice Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Humana Co.Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}